↓ Skip to main content

Michigan Publishing

Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent

Overview of attention for article published in JAMA Internal Medicine, February 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
4 news outlets
blogs
2 blogs
twitter
425 X users
facebook
3 Facebook pages

Citations

dimensions_citation
166 Dimensions

Readers on

mendeley
191 Mendeley
Title
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent
Published in
JAMA Internal Medicine, February 2020
DOI 10.1001/jamainternmed.2019.5284
Pubmed ID
Authors

Sean A. Woolen, Prasad R. Shankar, Joel J. Gagnier, Mark P. MacEachern, Lisa Singer, Matthew S. Davenport

X Demographics

X Demographics

The data shown below were collected from the profiles of 425 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 191 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 191 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 12%
Other 19 10%
Student > Ph. D. Student 19 10%
Student > Doctoral Student 15 8%
Student > Bachelor 15 8%
Other 43 23%
Unknown 58 30%
Readers by discipline Count As %
Medicine and Dentistry 85 45%
Chemistry 8 4%
Engineering 6 3%
Nursing and Health Professions 4 2%
Biochemistry, Genetics and Molecular Biology 3 2%
Other 19 10%
Unknown 66 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 320. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2024.
All research outputs
#106,256
of 25,543,275 outputs
Outputs from JAMA Internal Medicine
#690
of 11,668 outputs
Outputs of similar age
#2,683
of 473,681 outputs
Outputs of similar age from JAMA Internal Medicine
#16
of 110 outputs
Altmetric has tracked 25,543,275 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,668 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 85.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,681 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.